GE HealthCare Technologies Inc.
GEHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,672 | $19,552 | $18,341 | $17,585 |
| % Growth | 0.6% | 6.6% | 4.3% | – |
| Cost of Goods Sold | $11,467 | $11,630 | $11,162 | $10,411 |
| Gross Profit | $8,205 | $7,922 | $7,179 | $7,174 |
| % Margin | 41.7% | 40.5% | 39.1% | 40.8% |
| R&D Expenses | $1,311 | $1,205 | $1,026 | $816 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,269 | $4,282 | $3,631 | $3,563 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,580 | $5,487 | $4,657 | $4,379 |
| Operating Income | $2,625 | $2,435 | $2,522 | $2,795 |
| % Margin | 13.3% | 12.5% | 13.8% | 15.9% |
| Other Income/Exp. Net | -$44 | -$74 | -$10 | $80 |
| Pre-Tax Income | $2,581 | $2,361 | $2,512 | $2,875 |
| Tax Expense | $531 | $743 | $563 | $600 |
| Net Income | $1,993 | $1,568 | $1,916 | $2,247 |
| % Margin | 10.1% | 8% | 10.4% | 12.8% |
| EPS | 4.37 | 3.04 | 4.22 | 4.9 |
| % Growth | 43.8% | -28% | -13.9% | – |
| EPS Diluted | 4.34 | 3.02 | 4.22 | 4.9 |
| Weighted Avg Shares Out | 456 | 455 | 454 | 455 |
| Weighted Avg Shares Out Dil | 459 | 458 | 454 | 455 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $26 | $0 | $34 |
| Interest Expense | $505 | $542 | $86 | $40 |
| Depreciation & Amortization | $580 | $610 | $633 | $625 |
| EBITDA | $3,666 | $3,513 | $3,165 | $3,540 |
| % Margin | 18.6% | 18% | 17.3% | 20.1% |